BiotechTube
Home/Pipeline/MET FISH CDx

MET FISH CDx

NSCLC

CommercialApproved in China (with HUTCHMED)

Key Facts

Indication
NSCLC
Phase
Commercial
Status
Approved in China (with HUTCHMED)
Company
Amoy Diagnostics

About Amoy Diagnostics

A precision oncology diagnostics company developing PCR and NGS-based companion diagnostic kits for cancer, with a focus on accessibility and global partnerships.

View full company profile

Therapeutic Areas

Oncology

Other NSCLC Drugs

DrugCompanyPhase
REQORSAGenprexPhase 1/2
HBM7008Harbour BioMedPhase 1
HBM7004Harbour BioMedDiscovery
TJ108Phrontline BiopharmaIND-enabling
LR19125AVEO OncologyPre-clinical